• 1
    Hodgson TA, Greenspan D, Greenspan JS. Oral lesions of HIV disease and HAART in industrialized countries. Adv Dent Res 2006; 19: 5762.
  • 2
    Greenspan D, Canchola AJ, MacPhail LA, Cheikh B, Greenspan JS. Effect of highly active antiretroviral therapy on frequency of oral warts. Lancet 2001; 357: 14111412.
  • 3
    Diz Dios P, Scully C. Adverse effects of antiretroviral therapy: focus on orofacial effects. Expert Opin Drug Saf 2002; 1: 307317.
  • 4
    Scully C, Diz Dios P. Orofacial effects of antiretroviral therapies. Oral Dis 2001; 7: 205210.
  • 5
    Fagot JP, Mockenhaupt M, Bouwes-Bavinck JN, Naldi L, Viboud C, Roujeau JC. Nevirapine and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis. AIDS 2001; 15: 18431848.
  • 6
    Jordan RA. Implications of antiretroviral therapy in oral medicine–a review of literature]. Schweiz Monatsschr Zahnmed 2007; 117: 12101216.
  • 7
    Israr M, Mitchell D, Alam S, Dinello D, Kishel JJ, Meyers C. Effect of the HIV protease inhibitor amprenavir on the growth and differentiation of primary gingival epithelium. Antivir Ther 2010; 15: 253265.
  • 8
    Israr M, Mitchell D, Alam S, Dinello D, Kishel JJ, Meyers C. The HIV protease inhibitor lopinavir/ritonavir (Kaletra) alters the growth, differentiation and proliferation of primary gingival epithelium. HIV Med 2011; 12: 145156.
  • 9
    Mitchell D, Israr M, Alam S, Kishel J, Dinello D, Meyers C. Effect of the HIV nucleoside reverse transcriptase inhibitor zidovudine on the growth and differentiation of primary gingival epithelium. HIV Med 2012; 13: 276290.
  • 10
    Meyers C, Frattini MG, Hudson JB, Laimins LA. Biosynthesis of human papillomavirus from a continuous cell line upon epithelial differentiation. Science 1992; 257: 971973.
  • 11
    Meyers C. Organotypic (raft) epithelial tissue culture system for the differentiation dependent replication of papillomavirus. Methods Cell Sci 1996; 18: 110.
  • 12
    Cressey TR, Jourdain G, Rawangban B et al. Pharmacokinetics and virologic response of zidovudine/lopinavir/ritonavir initiated during the third trimester of pregnancy. AIDS 2010; 24: 21932200.
  • 13
    Cremieux AC, Katlama C, Gillotin C, Demarles D, Yuen GJ, Raffi F. A comparison of the steady-state pharmacokinetics and safety of abacavir, lamivudine, and zidovudine taken as a triple combination tablet and as abacavir plus a lamivudine-zidovudine double combination tablet by HIV-1-infected adults. Pharmacotherapy 2001; 21: 424430.
  • 14
    Unadkat JD, Collier AC, Crosby SS, Cummings D, Opheim KE, Corey L. Pharmacokinetics of oral zidovudine (azidothymidine) in patients with AIDS when administered with and without a high-fat meal. AIDS 1990; 4: 229232.
  • 15
    Klausner M, Ayehunie S, Breyfogle BA, Wertz PW, Bacca L, Kubilus J. Organotypic human oral tissue models for toxicological studies. Toxicol In Vitro 2007; 21: 938949.
  • 16
    Tomakidi P, Fusenig NE, Kohl A, Komposch G. Histomorphological and biochemical differentiation capacity in organotypic co-cultures of primary gingival cells. J Periodontal Res 1997; 32: 388400.
  • 17
    Mackenzie IC, Rittman G, Gao Z, Leigh I, Lane EB. Patterns of cytokeratin expression in human gingival epithelia. J Periodontal Res 1991; 26: 468478.
  • 18
    Bonan PR, Kaminagakura E, Pires FR, Vargas PA, Almeida OP. Cytokeratin expression in initial oral mucositis of head and neck irradiated patients. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006; 101: 205211.
  • 19
    Eichner R, Bonitz P, Sun TT. Classification of epidermal keratins according to their immunoreactivity, isoelectric point, and mode of expression. J Cell Biol 1984; 98: 13881396.
  • 20
    Paladini RD, Takahashi K, Bravo NS, Coulombe PA. Onset of re-epithelialization after skin injury correlates with a reorganization of keratin filaments in wound edge keratinocytes: defining a potential role for keratin 16. J Cell Biol 1996; 132: 381397.
  • 21
    Weiss RA, Eichner R, Sun TT. Monoclonal antibody analysis of keratin expression in epidermal diseases: a 48- and 56-kdalton keratin as molecular markers for hyperproliferative keratinocytes. J Cell Biol 1984; 98: 13971406.
  • 22
    Purkis PE, Steel JB, Mackenzie IC, Nathrath WB, Leigh IM, Lane EB. Antibody markers of basal cells in complex epithelia. J Cell Sci 1990; 97 (Pt 1): 3950.
  • 23
    Bernerd F, Magnaldo T, Darmon M. Delayed onset of epidermal differentiation in psoriasis. J Invest Dermatol 1992; 98: 902910.
  • 24
    Fuchs E, Green H. Changes in keratin gene expression during terminal differentiation of the keratinocyte. Cell 1980; 19: 10331042.
  • 25
    Bloor BK, Seddon SV, Morgan PR. Gene expression of differentiation-specific keratins (K4, K13, K1 and K10) in oral non-dysplastic keratoses and lichen planus. J Oral Pathol Med 2000; 29: 376384.
  • 26
    dos Santos JN, de Sousa SO, Nunes FD, Sotto MN, de Araujo VC. Altered cytokeratin expression in actinic cheilitis. J Cutan Pathol 2003; 30: 237241.
  • 27
    Bloor BK, Tidman N, Leigh IM et al. Expression of keratin K2e in cutaneous and oral lesions: association with keratinocyte activation, proliferation, and keratinization. Am J Pathol 2003; 162: 963975.
  • 28
    Pislariu CI, Murray JD, Wen J et al. A medicago truncatula tobacco retrotransposon insertion mutant collection with defects in nodule development and symbiotic nitrogen fixation. Plant Physiol 2012; 159: 16861699.
  • 29
    Celis JE, Celis A. Cell cycle-dependent variations in the distribution of the nuclear protein cyclin proliferating cell nuclear antigen in cultured cells: subdivision of S phase. Proc Natl Acad Sci U S A 1985; 82: 32623266.
  • 30
    Zuber M. Characterization of a cell cycle-dependent nuclear autoantigen. Mol Biol Rep 1996; 23: 197203.